|
|
Science Sparks @ ACTREC
|
10th June 2024 |
Vol. No. 13 ; Issue No.634 |
|
Publications
|
1. Juthani R, Punatar S Mittra I (2024). New light on chemotherapy toxicity and its prevention. BJC Reports. 2: 41.
2. Singh S, Mohammad N, Pal K, Pawar V, Saxena S, Khanna P (2024). Sonochemical synthesis of silver nanoparticles using orange juice: Cytotoxic behaviour and applications. Hybrid Advances
3. Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA (2024). RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International Journal of Gynecological Cancer.34(6):817-823.
4. Rajasimman AS, Patil V, Gala KB, Shetty N, Kulkarni S, Ramadwar MS, Qureshi SS, Chinnaswamy G, Laskar S, Baheti AD (2024). Accuracy of contrast-enhanced CT in liver neoplasms in children under 2 years age. Pediatric Radiology.
|
|
|
|
Video of the Week
|
|
Improving Cancer Detection & Treatment Through Implementation Science & Preclinical Models. |
|
|
|
|
|
|
Do You Know?
In 2018, FDA approved larotrectinib, the first drug that targets tumors with NTRK gene fusions.
|
|
|
Cancer News
|
|
|
|
|
100% of cancer patients cured long-term in 'remarkable' human trial.
|
News-Medical, 05/06/2024
|
The drug, Jemperli (dostarlimab-gxly), had earlier shown great potential for eliminating mismatch repair deficient (dMMR) cancers, which make up 5-10% of colorectal cancers. Following the Phase II trial, the first 24 patients assessed showed a "sustained complete clinical response"...
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|